Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Jazz Pharmaceuticals teams with AbCellera on cancer therapies as analysts maintain positive targets

The collaboration includes $56 million in upfront payments to AbCellera and up to $792 million in po

New late-breaking data presentations underscore Jazz's significant progress in advancing holisti

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced top-line results from the Phase 3 LAGOON tria

Jazz Pharma (JAZZ) revenue growth driven by Ziihera adoption as 1L treatment for HER2+ GEA, says Bof

Wall Street analysts change outlook on top names, including upgrades/downgrades. Check our analyst r

B of A Securities analyst Jason Gerberry maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that the company will present 21 abstracts, i